LATENT TUBERCULOSIS: TESTING AND RISK FACTOR ASSESSMENT IN POTENTIAL KIDNEY TRANSPLANT RECIPIENTS

被引：0
|
作者：
Rogerson, T. [1 ]
Pouladfar, G. [2 ]
Chen, S. [3 ]
Craig, J. [4 ]
Webster, A. [4 ]
机构：
[1] Univ Sydney, Sydney, NSW 2006, Australia
[2] Westmead Hosp, Ctr Transplant & Renal Res, Westmead, NSW, Australia
[3] Westmead Hosp, Ctr Infect Dis & Microbiol, Westmead, NSW, Australia
[4] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia
来源：
NEPHROLOGY | 2013年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
156
引用
收藏
页码：54 / 55
页数：2
相关论文
共 50 条
  • [31] Is Uric Acid an Independent Risk Factor for Graft Failure in Kidney Transplant Recipients?
    Kim, E.
    Famure, O.
    Li, Y.
    Kim, J.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 421 - 421
  • [32] Iron Overload Is a Major Risk Factor for Infectious Complications in Kidney Transplant Recipients
    Fernandez-Ruiz, M.
    Lopez-Medrano, F.
    Garcia-Reyne, A.
    Herrero-Martinez, J. M.
    Gonzalez, E.
    Polanco, N.
    San Juan, R.
    Lumbreras, C.
    Andres, A.
    Morales, J. M.
    Aguado, J. M.
    [J]. TRANSPLANTATION, 2012, 94 (10) : 78 - 78
  • [33] Role of interferon-gamma release assay for screening and monitoring of latent tuberculosis infection in kidney transplant recipients
    Bruminhent, Jackrapong
    Treekajonsak, Tanadon
    Kantachuvesiri, Surasak
    Setthaudom, Chavachol
    Sukkasem, Warawut
    Kawamatawong, Theerasuk
    [J]. BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [34] MATHEMATICAL MODEL FOR ADVERSE CARDIOVASCULAR EVENTS RISK ASSESSMENT IN KIDNEY TRANSPLANT RECIPIENTS
    Smaliakova, Maria
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I962 - I962
  • [35] Tacrolimus as a risk factor for tuberculosis and outcome of treatment with rifampicin in solid organ transplant recipients
    Ha, Y. E.
    Joo, E. J.
    Park, S. Y.
    Wi, Y. M.
    Kang, C. I.
    Chung, D. R.
    Joh, J. W.
    Lee, S. K.
    Song, J. H.
    Peck, K. R.
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2012, 14 (06) : 626 - 634
  • [36] Safety and outcome of treatment of latent tuberculosis infection in liver transplant recipients
    Lee, Yun Woo
    Chung, Hyemin
    Kim, Sung-Han
    Sung, Heungsup
    Ha, Su-Min
    Jwa, Eun-Kyoung
    Jung, Dong-Hwan
    Moon, Deok-Bog
    Lee, Sung-Gyu
    Lee, Sang-Oh
    [J]. INFECTION, 2024, 52 (03) : 1055 - 1061
  • [37] Thrombotic risk of EPO in kidney transplant recipients
    [J]. Nature Reviews Nephrology, 2012, 8 (5) : 253 - 253
  • [38] Latent cytomegalovirus infection is an independent risk factor for late graft failure in renal transplant recipients
    van Ree, Rutger M.
    de Vries, Aiko P. J.
    Zelle, Dorien M.
    de Vries, Laura V.
    Oterdoom, Leendert H.
    Gans, Reinold O. B.
    Schouten, Jan P.
    Lems, Simon P. M.
    van Son, Willem J.
    Bakker, Stephan J. L.
    [J]. MEDICAL SCIENCE MONITOR, 2011, 17 (11): : CR609 - CR617
  • [39] Risk factors and clinical outcomes of tuberculosis among kidney transplant recipients in high endemic country
    Thitisuriyarax, Saranya
    Vanichanan, Jakapat
    Udomkarnjananun, Suwasin
    Townamchai, Natavudh
    Jutivorakool, Kamonwan
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2021, 23 (03)
  • [40] Tuberculosis in Kidney Transplant Recipients: A Nationwide Cohort in a Low Tuberculosis Incidence Country
    Feuth, Thijs
    Rajalahti, Iiris
    Vasankari, Tuula
    Gissler, Mika
    Rimhanen-Finne, Ruska
    Finne, Patrik
    Helantera, Ilkka
    [J]. TRANSPLANTATION DIRECT, 2023, 9 (09): : E1527
12345